
PT-141
The melanocortin desire peptide — central, not vascular
Kisspeptin is the master switch that sits one step above GnRH in the chain that controls reproductive hormones. Give it, and the body releases its own pulse of LH, which raises testosterone through its own machinery rather than replacing it. KSP-10 is the 10-amino-acid active fragment.
Includes 10× sterile insulin syringes + 1 vial of bacteriostatic water, free with your order.
For research and educational use only. Not for human or veterinary consumption.
What human studies show:
What people use it for:
It is not testosterone and not a TRT. The effect is a pulse, not a sustained level. It won't produce the steady high testosterone that injected testosterone does.
The human data is almost entirely intravenous. The clean trial results were IV boluses and infusions. There is no validated subcutaneous protocol, and subcutaneous kisspeptin-10 did not reliably raise LH in some studies. Injecting it under the skin is an extrapolation, not a proven method.
It does not work better the more constant it is — the opposite. Continuous or repeated exposure causes the receptor to desensitise. In one two-week study the hormone response was much weaker on day 14 than on day 1. Spacing is not optional.
It is very short-lived. Kisspeptin-10's half-life in people is only about 4 minutes, so any effect from a single dose is brief.
It does not restart a shut-down axis on its own. For post-cycle use, treat it as one possible tool, not a protocol — and talk to someone who knows your bloodwork.
Reported in trials: remarkably few. Across the human kisspeptin studies, side effects were minimal, and the IVF trigger work found no moderate-to-severe ovarian hyperstimulation. It does not carry Melanotan's or PT-141's nausea-and-flushing profile.
Theoretical and practical:
Stop and see a doctor: swelling of the face, lips or throat, or difficulty breathing (rare allergic reaction); or, if you are tracking fertility, any unexpected change.
🛑 Don't use it if pregnant, breastfeeding, under 18, or managing a hormone-sensitive condition without your doctor.
Draw past the line, tap out bubbles, push back to the line.
The AVERON Peptide Pen delivers 1 click = 0.01 mL. A U-100 insulin syringe delivers 1 unit = 0.01 mL. They are the same number. 20 clicks on the pen and 20 units on a syringe deliver exactly the same dose.
Maximum per injection: 100 units (1 mL)
10 mg vial + 2 mL bacteriostatic water = 5 mg/mL
| Dose | Volume | Units (U-100) |
|---|---|---|
| 250 mcg | 0.05 mL | 5 |
| 500 mcg | 0.10 mL | 10 |
| 1 mg | 0.20 mL | 20 |
Inject the water slowly down the inside wall of the vial. Swirl gently, never shake. It should be clear with no particles. Refrigerate at 2–8 °C and use within 4 weeks.
Draw past the line, tap out bubbles, push back to the line.
The AVERON Peptide Pen delivers 1 click = 0.01 mL. A U-100 insulin syringe delivers 1 unit = 0.01 mL. They are the same number. 20 clicks on the pen and 20 units on a syringe deliver exactly the same dose.
Maximum per injection: 100 units (1 mL)
There is no validated subcutaneous dose. The published human doses were intravenous and weight-based, which doesn't translate cleanly to a subcutaneous injection you give yourself. The community range is 500 mcg to 1 mg, every other day — never daily, because of the desensitisation above. Many people split it into two smaller injections to stay closer to the natural pulse.
Every other day is the one firm rule. Daily dosing shuts the response down, which is the opposite of what you want. Cycle it — a few weeks on, then off — rather than running it continuously.
We'd rather be straight with you: this is one of the compounds where the gap between the clean trial data (IV, in a lab) and how people actually use it (subcutaneous, at home) is wide. Message us on WhatsApp if you want to talk it through.
Kisspeptin has a solid and growing human research base — but it is a research compound, not an approved medicine anywhere. The strongest work comes from Imperial College London: IV kisspeptin-10 and -54 raising LH and testosterone in men, the sharp sex difference in women, desensitisation with repeated dosing, a brain-imaging study on sexual and emotional processing, and kisspeptin-54 as an IVF egg-maturation trigger with very low ovarian-hyperstimulation risk. Note that several of the landmark results used kisspeptin-54, the longer peptide, not the -10 fragment we supply.
Athletes: kisspeptin and its agonist analogues are named on the WADA 2026 list (S2) — prohibited at all times.
Every peptide batch we sell is tested by Janoshik Analytical, an independent laboratory. Every vial carries an internal AVERON batch code identifying the lot received; each lot is linked to its published Janoshik report. The report carries the manufacturer's submission/task number, not the AVERON code. Ask us or our driver which report covers your code and open it on the laboratory's own website before paying. In our own-driver zone, the team shows you the vial and the report for that batch before payment.
A lab report handed to you by a seller and a lab report you can verify yourself are not the same thing. That's why we publish ours.
View COA on Janoshik
The melanocortin desire peptide — central, not vascular


Once-weekly GLP-1 with the deepest trial record in its class